Oryx International Growth Fund Ld
09 October 2006
For immediate release
Not for release, publication or distribution, in whole or in part, in or into
the United States, Canada, Australia, South Africa or Japan
9 October 2006
Offer by Arbuthnot Securities Limited
on behalf of Oryx International Growth Fund Limited ('Oryx')
for Baltimore Capital plc (formerly Baltimore plc) ('Baltimore')
(the 'Offer')
OFFER UPDATE
On 27 July 2006, Oryx announced that the Offer was wholly unconditional and that
the closing date of the Offer had been extended to remain open for acceptance
until further notice. As at 1.00 p.m. on 2 October 2006, Oryx had received
valid acceptances of the Offer in respect of 141,117,533 Baltimore Shares,
representing approximately 90.34 per cent. of Baltimore's current issued share
capital and approximately 90.75 per cent. of the Baltimore Shares to which the
Offer relates.
Since Oryx has now received acceptances under the Offer in respect of more than
90 per cent. of the Baltimore Shares to which the Offer relates it is entitled
to exercise its rights under the provisions of Sections 428 to 430F (inclusive)
of the Act to acquire compulsorily the remaining Baltimore Shares. Accordingly,
formal notices, under Section 429 of the Act, are today being posted to those
Baltimore Shareholders who have not yet accepted the Offer. Baltimore
Shareholders should be aware that they may still accept the Offer, which remains
open for acceptance until 1.00 p.m. on 23 October 2006, rather than waiting for
their Baltimore Shares to be compulsorily acquired by Oryx.
The Offer will remain open for acceptance for a further 14 days and the Offer
will therefore close at 1.00 p.m. on 23 October 2006. Baltimore Shareholders
who wish to accept the Offer but who have not yet done so, should either return
their completed Forms of Acceptance (and supporting documents) or if their
Baltimore Shares are held in CREST, arrange for their CREST sponsor to send the
relevant TTE instruction(s) to CRESTCo, in accordance with the procedures set
out in the Offer Document as soon as possible.
Terms defined in the Offer Document shall, unless the context requires
otherwise, have the same meanings in this announcement.
Enquiries:
Arbuthnot Securities Limited Tel: 020 7012 2000
Alastair Moreton
Arbuthnot Securities Limited, which is authorised and regulated in the United
Kingdom by the Financial Services Authority, is acting exclusively for Oryx and
no one else in connection with the Offer and will not be responsible to anyone
other than Oryx for providing the protections afforded to customers of Arbuthnot
Securities Limited or for providing advice in relation to the Offer or any other
matter referred to herein.
The Offer is not being made, directly or indirectly, in or into, and may not be
accepted in or from, the United States, Canada, Australia, South Africa or
Japan. Accordingly, copies of this announcement are not being, and must not be,
mailed or otherwise distributed or sent in or into or from the United States,
Canada, Australia, South Africa or Japan.
Arbuthnot has approved the contents of this announcement solely for the purpose
of Section 21 of the Financial Services and Markets Act 2000. The principal
place of business of Arbuthnot Securities Limited is Arbuthnot House, 20
Ropemaker Street, London EC2Y 9AR.
This announcement does not constitute, or form part of, an offer or invitation
to purchase any securities.
This information is provided by RNS
The company news service from the London Stock Exchange
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.